New Delhi [India], September 9 (ANI): The GST Council that met on Monday decided to reduce the GST rate on certain cancer drugs from 12 per cent to 5 per cent, aimed at reducing the overall cost of cancer treatment. Those drugs are Trastuzumab Deruxtecan, Osimertinib, and Durvalumab. In another decision, GST rate has been […]